Otsuka Pharmaceutical Co., Ltd. is a global healthcare company with the corporate philosophy: “Otsuka–people creating new products for better health worldwide.” In the U.S., Otsuka is comprised of two companies, Otsuka America Pharmaceutical, Inc., and Otsuka Pharmaceutical Development & Commercialization, Inc., that share a deep commitment to the development and commercialization of innovative products in neuroscience, nephrology, and digital medicine.
Driven by our purpose to defy limitation, so that others can too, we have an unwavering belief in doing more and transcending expectations by going above and beyond—under any and all circumstances—for patients, families, providers, and for each other. It’s this deep-rooted dedication that drives us to uncover answers to complex, underserved medical needs, so that patients can push past the limitations of their disease and achieve more than they thought was possible each and every day.
OPDC and OAPI are indirect subsidiaries of Otsuka Pharmaceutical Company, Ltd., which is a subsidiary of Otsuka Holdings Co., Ltd. headquartered in Tokyo, Japan. The Otsuka group of companies employed 47,000 people worldwide and had consolidated sales of approximately USD 13 billion in 2019.
Our employees, who we endearingly refer to as Otsuka-people, are excited to share their time and knowledge with schools implementing the Parents Care Program© and the students and parents of Middle School 354. Our employees all have Bachelor’s degrees, and many with advanced degrees in science, technology, engineering and mathematics which help support STEM curriculum and careers in the sciences.
Our volunteers hope to foster a connection with the children and their parents to support them on their educational journeys, meeting them where they are and providing the assistance that is most meaningful and beneficial to them.
KABIR NATH, PRESIDENT & CEO
EDUCATION LEADERSHIP HONOREE